Elixir Energy Limited - EXR.AX

EXR.AX Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
EXR.AX	-2	-5.8	16.7	-22.2	-55.5	-34.7	-70.3	145	19.8	-98.6
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare EXR.AX with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	EXR.AX
name	Elixir Energy Limited
price	0.049
changes percentage	-2
change	-0.001
day low	0.046
day high	0.052
year high	0.2075
year low	0.04
market cap	58643690
price avg 50	0.0476
price avg 200	0.096588
exchange	ASX
volume	950542
avg volume	1994829
open	0.052
previous close	0.05
eps	0
pe	None
earnings announcement	2025-02-21T10:59:00.000+0000
shares outstanding	1196810000
timestamp	2025-01-20 05:10:41

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 31.3%

Overall Quarterly Financial Health: 26.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	1671820	0	NaN
gross profit	1000000	-24870	4120.91
gross profit ratio	0.6	0	NaN
research and development expenses	0	0	NaN
operating expenses	2647786	3257227	-18.71
interest income	254381	312985	-18.72
interest expense	100309	0	NaN
ebitda	-1370785	-3257227	57.92
ebitdaratio	-0.82	0	NaN
operating income	-1647786	-3282100	49.79
operating income ratio	-0.99	0	NaN
net income	-1594816	-2942854	45.81
net income ratio	-0.95	0	NaN
eps	-0.0	-0.0	56.25

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 2 million in 2024 from 0 million in 2023 representing a change of nan%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1 million in 2024 from 0 million in 2023 representing a change of 4120.91%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 3 million in 2024 from 3 million in 2023 representing a change of -18.71%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

• 📉 Negative Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -1 million in 2024 from -3 million in 2023 representing a change of 57.92%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -2 million in 2024 from -3 million in 2023 representing a change of 49.79%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -2 million in 2024 from -3 million in 2023 representing a change of 45.81%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
revenue	0	1671820	-100.00
gross profit	-15094	984924	-101.53
gross profit ratio	0	0.59	-100.00
research and development expenses	0	0	NaN
operating expenses	1158544	1489242	-22.21
interest income	121649	132732	-8.35
interest expense	0	0	NaN
ebitda	-1089045	-489242	-122.60
ebitdaratio	0	-0.29	100.00
operating income	-1158544	-504320	-129.72
operating income ratio	0	-0.3	100.00
net income	-1197685	-397131	-201.58
net income ratio	0	-0.24	100.00
eps	-0.0	-0.0	-125.00

Overall Score of Quarterly Income Statement

0.17 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 0 million in 2024Q4 from 2 million in 2024Q2 representing a change of -100.0%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 0 million in 2024Q4 from 1 million in 2024Q2 representing a change of -101.53%. This indicates a sales profitability decline, which is a negative sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -1 million in 2024Q4 from 0 million in 2024Q2 representing a change of -122.6%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -1 million in 2024Q4 from -1 million in 2024Q2 representing a change of -129.72%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -1 million in 2024Q4 from 0 million in 2024Q2 representing a change of -201.58%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 1 million in 2024Q4 from 1 million in 2024Q2 representing a change of -22.21%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	62338917	43332967	43.86
total liabilities	8801628	497074	1670.69
total equity	53537289	42835893	24.98
cash and cash equivalents	7665422	9555235	-19.78
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	16528709	10850908	52.33
total non current assets	45810208	32482058	41.03
total current liabilities	8769917	460209	1805.64
total non current liabilities	31711	36865	-13.98
common stock	138913182	123116684	12.83
retained earnings	-82600560	-81192424	-1.73
total debt	6345763	46957	13413.99

Overall Score of Annual Balance Sheet

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 62 million in 2024 from 43 million in 2023 representing a change of 43.86%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 54 million in 2024 from 43 million in 2023 representing a change of 24.98%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 17 million in 2024 from 11 million in 2023 representing a change of 52.33%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 139 in 2024 from 123 in 2023 representing a change of 12.83%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 9 million in 2024 from 0 million in 2023 representing a change of 1670.69%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 8 million in 2024 from 10 million in 2023 representing a change of -19.78%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 9 million in 2024 from 0 million in 2023 representing a change of 1805.64%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -83 million in 2024 from -81 million in 2023 representing a change of -1.73%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 6 million in 2024 from 0 million in 2023 representing a change of 13413.99%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
total assets	62338917	60196220	3.56
total liabilities	8801628	3885201	126.54
total equity	53537289	56311019	-4.93
cash and cash equivalents	7665422	11224945	-31.71
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	16528709	17801425	-7.15
total non current assets	45810208	42394795	8.06
total current liabilities	8769917	3854949	127.50
total non current liabilities	31711	30251	4.83
common stock	138913182	138769237	0.10
retained earnings	-82600560	-81439127	-1.43
total debt	6345763	122100	5097.19

Overall Score of Quarterly Balance Sheet

0.22 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 62 million in 2024Q4 from 60 million in 2024Q2 representing a change of 3.56%. Suggesting a growth in asset holdings.

  Common Stock: Common Stock increased to 139 in 2024Q4 from 139 in 2024Q2 representing a change of 0.1%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 9 million in 2024Q4 from 4 million in 2024Q2 representing a change of 126.54%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 54 million in 2024Q4 from 56 million in 2024Q2 representing a change of -4.93%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 8 million in 2024Q4 from 11 million in 2024Q2 representing a change of -31.71%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 17 million in 2024Q4 from 18 million in 2024Q2 representing a change of -7.15%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 9 million in 2024Q4 from 4 million in 2024Q2 representing a change of 127.5%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -83 million in 2024Q4 from -81 million in 2024Q2 representing a change of -1.43%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 6 million in 2024Q4 from 0 million in 2024Q2 representing a change of 5097.19%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	-1889813	-13123984	85.60
operating cash flow	-1364998	-1732240	21.20
free cash flow	-22772366	-13190217	-72.65
capital expenditure	-21822477	-11457977	-90.46
depreciation and amortization	30170	24870	21.31
deferred income tax	0	-51079.48	100.00
stock based compensation	0	1339476	-100.00
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-21822477	-11457977	-90.46
net cash used for investing activites	-21152987	-11457977	-84.61
debt repayment	6245000	0	NaN
common stock issued	15358979	0	NaN
common stock repurchased	0	-11010	100.00
dividends paid	0	0	NaN
net cash used provided by financing activities	20640496	-11010	187570.45
cash at end of period	7665422	9555235	-19.78
accounts receivables	0	0	NaN
cash at beginning of period	9555235	22679219	-57.87

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
operating cash flow	-257898	-974368	73.53
free cash flow	-10090547	-12964196	22.17
capital expenditure	-9832649	-11989828	17.99
depreciation and amortization	15094	15076	0.12
deferred income tax	0	0	NaN
stock based compensation	183389	51385	256.89
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-9832649	-11989828	17.99
net cash used for investing activites	-9711000	-11574719	16.10
debt repayment	0	0	NaN
common stock issued	139443	14256053	-99.02
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	6384443	14256053	-55.22
net change in cash	-3559523	1669710	-313.18
cash at end of period	7665422	11224945	-31.71
cash at beginning of period	11224945	9555235	17.47

Overall Score of Quarterly Cashflow Statement

0.4 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -4 million in 2024Q4 from 2 million in 2024Q2 representing a change of -313.18%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -10 million in 2024Q4 from -12 million in 2024Q2 representing a change of 17.99%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 0 million in 2024Q4 from 0 million in 2024Q2 representing a change of 256.89%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 0 million in 2024Q4 from -1 million in 2024Q2 representing a change of 73.53%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -10 million in 2024Q4 from -13 million in 2024Q2 representing a change of 22.17%. This indicates an increase in cash generated after accounting for capital expenditures.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-06-30	2023-06-30	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	0.0	0	NaN
net income per share	-0.0	-0.0	57.42
operating cash flow per share	-0.0	-0.0	38.08
free cash flow per share	-0.02	-0.01	-35.66
cash per share	0.01	0.01	-36.96
book value per share	0.05	0.05	-1.79
tangible book value per share	0.05	0.05	-1.79
shareholders equity per share	0.05	0.05	-1.79
interest debt per share	0.01	0.0	10687.08
market cap	108769503.72	72740865.28	49.53
enterprise value	107449844.72	63232587.28	69.93
pe ratio	-68.2	-24.72	-175.92
price to sales ratio	65.06	0	NaN
pocfratio	-79.68	-41.99	-89.76
pfcf ratio	-4.78	-5.51	13.39
pb ratio	2.03	1.7	19.64
ptb ratio	2.03	1.7	19.64
ev to sales	64.27	0	NaN
enterprise value over ebitda	-78.39	-19.41	-303.78
ev to operating cash flow	-78.72	-36.5	-115.65
ev to free cash flow	-4.72	-4.79	1.57
earnings yield	-0.01	-0.04	63.76
free cash flow yield	-0.21	-0.18	-15.46
debt to equity	0.12	0.0	10712.72
debt to assets	0.1	0.0	9293.83
net debt to ebitda	0.96	2.92	-67.02
current ratio	1.88	23.58	-92.01
interest coverage	-16.43	0	NaN
income quality	0.86	0.59	45.41
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	1.39	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	-15.99	-6.61	-141.70
capex to revenue	13.05	0	NaN
capex to depreciation	723.32	460.71	57.00
stock based compensation to revenue	0	0	NaN
graham number	0.04	0.06	-35.33
roic	-0.03	-0.07	59.86
return on tangible assets	-0.03	-0.07	62.33
graham net net	0.0	0.01	-54.54
working capital	7758792	10390699	-25.33
tangible asset value	53537289	42835893	24.98
net current asset value	7727081	10353834	-25.37
invested capital	53569000	11333832	372.65
average receivables	4244703	35187	11963.27
average payables	882538	571814.5	54.34
average inventory	276107.5	168698	63.67
days sales outstanding	1853.45	0	NaN
days payables outstanding	878.25	2180.52	-59.72
days of inventory on hand	116.71	4951.73	-97.64
receivables turnover	0.2	0	NaN
payables turnover	0.42	0.17	148.28
inventory turnover	3.13	0.07	4142.72
roe	-0.03	-0.07	56.64
capex per share	0.02	0.01	49.66

• Negative

  ROE: Return on Equity (ROE) increased to -0.03 on 2024-06-30 from -0.07 on 2023-06-30, representing a change of 56.64%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -68.20 on 2024-06-30 from -24.72 on 2023-06-30, representing a change of -175.92%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.88 on 2024-06-30 from 23.58 on 2023-06-30, representing a change of -92.01%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.12 on 2024-06-30 from 0.00 on 2023-06-30, representing a change of 10712.72%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q4	2023-12-31 Q2	Q/Q change %
EXR.AX
calendar year	2024	2024	NaN
revenue per share	0	0.0	-100.00
net income per share	-0.0	-0.0	-126.50
operating cash flow per share	-0.0	-0.0	80.12
free cash flow per share	-0.01	-0.01	41.54
cash per share	0.01	0.01	-48.71
book value per share	0.04	0.06	-28.60
tangible book value per share	0.04	0.06	-28.60
shareholders equity per share	0.04	0.06	-28.60
interest debt per share	0.0	0.0	3803.26
market cap	124263123.56	82404682.5	50.80
enterprise value	122943464.56	71301837.5	72.43
pe ratio	-25.94	-51.88	50.00
price to sales ratio	0	49.29	-100.00
pocfratio	-481.83	-84.57	-469.73
pfcf ratio	-12.31	-6.36	-93.74
pb ratio	2.32	1.46	58.61
ptb ratio	2.32	1.46	58.61
ev to sales	0	42.65	-100.00
enterprise value over ebitda	-112.89	-145.74	22.54
ev to operating cash flow	-476.71	-73.18	-551.45
ev to free cash flow	-12.18	-5.5	-121.53
earnings yield	-0.01	-0.0	-99.99
free cash flow yield	-0.08	-0.16	48.38
debt to equity	0.12	0.0	5366.45
debt to assets	0.1	0.0	4918.55
net debt to ebitda	1.21	22.69	-94.66
current ratio	1.88	4.62	-59.19
interest coverage	0	0	NaN
income quality	0.22	2.45	-91.22
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0.85	-100.00
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	-38.13	-12.31	-209.84
capex to revenue	0	7.17	-100.00
capex to depreciation	651.43	795.29	-18.09
stock based compensation to revenue	0	0.03	-100.00
graham number	0.03	0.02	27.17
roic	-0.02	-0.01	-134.83
return on tangible assets	-0.02	-0.01	-191.22
graham net net	0.0	0.01	-65.80
working capital	7758792	13946476	-44.37
tangible asset value	53537289	56311019	-4.93
net current asset value	7727081	13916224	-44.47
invested capital	53569000	15037508	256.24
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	0	305.22	-100.00
days payables outstanding	9638.61	342.3	2715.85
days of inventory on hand	1280.89	34.45	3617.65
receivables turnover	0	0.29	-100.00
payables turnover	0.01	0.26	-96.45
inventory turnover	0.07	2.61	-97.31
roe	-0.02	-0.01	-217.21
capex per share	0.01	0.01	-38.41

• Negative

  ROE: Return on Equity (ROE) decreased to -0.02 on 2024-06-30 Q4 from -0.01 on 2023-12-31 Q2, representing a change of -217.21%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to -25.94 on 2024-06-30 Q4 from -51.88 on 2023-12-31 Q2, representing a change of 50.00%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.88 on 2024-06-30 Q4 from 4.62 on 2023-12-31 Q2, representing a change of -59.19%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.12 on 2024-06-30 Q4 from 0.00 on 2023-12-31 Q2, representing a change of 5366.45%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 0.01 which is lower than current price 0.05, indicates the company may be overvalued.